Liaoning Chengda Biotechnology Co.,Ltd.’s Net Profit Dropped 15.8% in First Quarter of 2023

Liaoning Chengda Biotechnology Co.,Ltd. (辽宁成大生物股份有限公司) (688739.SH) reported a net profit of 127 million yuan in the first quarter of 2023, down 15.8% year-on-year.

Meanwhile, the company posted 353.5 million yuan in revenue, down 3.5% year-on-year.

At the end of the reporting period, it had 10.1 billion yuan in total assets and 329 million yuan in total liabilities, with a liability-to-asset ratio of 3.3%.